Related Experiment Video
Updated: Apr 7, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Pediatric vasculitis: advances in treatment.
Kimberly Morishita1, Kelly Brown, David Cabral
1Division of Rheumatology, Department of Pediatrics, British Columbia's Children's Hospital, University of British Columbia, Vancouver, Canada.
Recent advances in treating childhood systemic vasculitis show improved outcomes. Newer biologic agents like rituximab are increasingly effective, complementing traditional therapies and driving evidence-based pediatric guidelines.
Area of Science:
- Pediatric rheumatology
- Systemic vasculitis treatment
Background:
- Chronic primary systemic vasculitis impacts children.
- Traditional treatments include cyclophosphamide and corticosteroids.
Purpose of the Study:
- Provide an overview of recent advances in treating childhood chronic systemic vasculitis.
Main Methods:
- Review of current literature and treatment strategies.
- Analysis of data from international registries and multicentered initiatives.
Main Results:
- Significant improvements in patient outcomes over recent decades.
- Growing evidence supports newer treatments like rituximab and biologics.
- Enhanced research and pediatric-specific data generation through collaboration.
Conclusions:
- Pediatric data on vasculitis treatment are accumulating.
- Evidence for novel treatments and alternative strategies is evolving.
- Future development of evidence-based guidelines and assessment tools is crucial.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrotic Syndrome II : Assessment and Medical Management
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Myocarditis III: Medical Management
Pharmacokinetics in Pediatric Patients: Drug Excretion

